Latest News
Feature
Coming soon: CAR T-cell approvals in multiple myeloma
CAR T-cell approvals for multiple myeloma are on the horizon and will transform oncology, according to Dr. Carl June.
From the Journals
World Trade Center responders face greater cancer burden, including greater risk of multiple myeloma
The prevalence of multiple myeloma precursor disease was more than threefold higher in WTC exposed firefighters.
Conference Coverage
Experts offer guidance on use of emicizumab
SAN DIEGO – Emicizumab will likely provide a paradigm shift in managing hemophilia A with inhibitor antibodies.
Daily News Podcast
MDedge Daily News: Lupus is quietly killing young women
And does substance abuse trigger schizophrenia?
Feature
What’s in a name? Get ready for the feds’ Promoting Interoperability program
Will a name change soothe clinicians’ dislike of federal IT programs? You decide.
Conference Coverage
Probe linked to smartphone found effective in diagnosing oral cancer
DALLAS – The device provides high-resolution polarized white light images in combination with autofluorescence imaging capability.
From the Journals
Early breast cancer: Patients report favorable quality of life after partial breast irradiation
Moreover, breast symptom scores were worse for whole breast radiation in the study.
From the Journals
Screening tool IDs older NSCLC patients suitable for SBRT
Patients with higher G8 screening tool scores had significantly better survival of non–small cell lung cancer after stereotactic body radiotherapy...
News
FDA places partial hold on trials after secondary lymphoma
A pediatric patient developed a secondary T-cell lymphoma during a phase 1 trial of tazemetostat.
Daily News Podcast
MDedge Daily News: Which nonopioids are ripe for abuse?
And bum kidneys shouldn’t stop dabigatran reversal.
From the Journals
Hormone therapy raises diabetes risk in breast cancer survivors
Tamoxifen and aromatase inhibitors were associated with increased risk for diabetes in a case-cohort study in Israel.